A PHASE-III TRIAL COMPARING VOROZOLE (RIVIZOR(TM)) VERSUS AMINOGLUTETHIMIDE IN THE TREATMENT OF ADVANCED POSTMENOPAUSAL BREAST-CANCER

Citation
No. Bengtsson et al., A PHASE-III TRIAL COMPARING VOROZOLE (RIVIZOR(TM)) VERSUS AMINOGLUTETHIMIDE IN THE TREATMENT OF ADVANCED POSTMENOPAUSAL BREAST-CANCER, European journal of cancer, 33, 1997, pp. 656-656
Citations number
NO
Categorie Soggetti
Oncology
Journal title
ISSN journal
09598049
Volume
33
Year of publication
1997
Supplement
8
Pages
656 - 656
Database
ISI
SICI code
0959-8049(1997)33:<656:APTCV(>2.0.ZU;2-Q